A sector-based dosimetric analysis of dose heterogeneity in high-dose-rate prostate brachytherapy

There is significant intra-prostatic dose heterogeneity in prostate HDR brachytherapy. This is most notable in the increased dose to base and lateral portions of the gland. Further studies are needed to determine the impact of heterogeneity on clinical outcomes.